Nebraska Statutes
§ 71-9607 — Death of patient; effect on debt
Nebraska § 71-9607
JurisdictionNebraska
Ch. 71Public Health and Welfare
This text of Nebraska § 71-9607 (Death of patient; effect on debt) is published on Counsel Stack Legal Research, covering Nebraska primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Neb. Rev. Stat. § 71-9607 (2026).
Text
If an eligible patient dies while being treated by an investigational drug, biological product, or device, the manufacturer may not seek reimbursement for any outstanding debt related to the treatment or lack of insurance due to the treatment from the eligible patient's or his or her caretaker's estate.
Free access — add to your briefcase to read the full text and ask questions with AI
Legislative History
Source: Laws 2018, LB117, § 7.
Nearby Sections
15
§ 71-1002
Repealed. Laws 2019, LB559, § 6§ 71-1005
Repealed. Laws 2019, LB559, § 6§ 71-1006
Repealed. Laws 2019, LB559, § 6§ 71-1007
Board; purpose§ 71-101
Transferred to section38-101§ 71-101.01
Repealed. Laws 2007, LB 463, § 1319§ 71-101.02
Repealed. Laws 1988, LB 1100, § 185§ 71-102
Transferred to section38-121§ 71-103
Transferred to section38-129§ 71-104.01
Transferred to section38-131§ 71-105
Transferred to section38-122Cite This Page — Counsel Stack
Bluebook (online)
Nebraska § 71-9607, Counsel Stack Legal Research, https://law.counselstack.com/statute/ne/71-9607.